Abeona Therapeutics (ABEO) Leases: 2019-2025
Historic Leases for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to $4.1 million.
- Abeona Therapeutics' Leases rose 7.84% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 7.84%. This contributed to the annual value of $3.6 million for FY2024, which is 20.27% down from last year.
- Abeona Therapeutics' Leases amounted to $4.1 million in Q3 2025, which was down 1.40% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Leases registered a high of $9.4 million during Q4 2021, and its lowest value of $3.6 million during Q4 2024.
- For the 3-year period, Abeona Therapeutics' Leases averaged around $4.3 million, with its median value being $4.2 million (2024).
- Per our database at Business Quant, Abeona Therapeutics' Leases soared by 33.72% in 2021 and then crashed by 43.31% in 2022.
- Abeona Therapeutics' Leases (Quarterly) stood at $9.4 million in 2021, then crashed by 43.31% to $5.3 million in 2022, then decreased by 16.43% to $4.5 million in 2023, then dropped by 20.27% to $3.6 million in 2024, then rose by 7.84% to $4.1 million in 2025.
- Its last three reported values are $4.1 million in Q3 2025, $4.1 million for Q2 2025, and $4.2 million during Q1 2025.